Intracranial hemorrhage in patients with cancer treated with bevacizumab: The memorial Sloan-Kettering experience Academic Article uri icon

Overview

MeSH Major

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Brain Neoplasms
  • Intracranial Hemorrhages
  • Neoplasms

abstract

  • ICH with bevacizumab treatment in this population is rare and does not appear to increase its frequency over the baseline rate of ICH in a comparable population. Most bevacizumab-related ICH occurs into central nervous system tumors but spontaneous hemorrhages were seen.

publication date

  • February 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1093/annonc/mdr148

PubMed ID

  • 21543627

Additional Document Info

start page

  • 458

end page

  • 63

volume

  • 23

number

  • 2